Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
38.50
+1.50 (4.05%)
Nov 9, 2026, 11:30 AM EST - Market open
Acadia Healthcare Company Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,579 | 1,309 | 3,683 | 7,171 | 7,489 | 5,459 | |
Market Cap Growth | 87.60% | -64.45% | -48.64% | -4.25% | 37.19% | 22.05% |
Enterprise Value | 5,943 | 3,811 | 5,750 | 8,703 | 9,055 | 6,893 |
Last Close Price | 37.00 | 14.19 | 39.65 | 77.76 | 82.32 | 60.70 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 14.41 | - | 27.42 | 28.64 |
Forward PE | 19.38 | 8.21 | 11.61 | 21.49 | 25.32 | 21.21 |
PS Ratio | 1.01 | 0.40 | 1.17 | 2.45 | 2.87 | 2.36 |
PB Ratio | 1.66 | 0.61 | 1.15 | 2.48 | 2.58 | 2.11 |
P/TBV Ratio | 5.67 | 2.36 | 4.99 | 14.85 | 14.57 | 22.07 |
P/FCF Ratio | - | - | - | 187.68 | 88.71 | 42.10 |
P/OCF Ratio | 14.63 | 9.93 | 28.40 | 15.51 | 19.68 | 14.58 |
PEG Ratio | 18.82 | 27.20 | 1.91 | 2.08 | 2.02 | 2.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.70 | 1.15 | 1.82 | 2.97 | 3.47 | 2.98 |
EV/EBITDA Ratio | 10.85 | 6.60 | 8.56 | 13.62 | 16.06 | 13.70 |
EV/EBIT Ratio | 17.41 | 9.82 | 11.01 | 17.18 | 20.29 | 17.38 |
EV/FCF Ratio | - | - | - | 227.78 | 107.26 | 53.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.12 | 1.24 | 0.66 | 0.52 | 0.53 | 0.64 |
Debt / EBITDA Ratio | 4.34 | 4.25 | 2.91 | 2.20 | 2.53 | 3.04 |
Debt / FCF Ratio | - | - | - | 39.54 | 18.25 | 12.72 |
Net Debt / Equity Ratio | 1.05 | 1.18 | 0.63 | 0.49 | 0.50 | 0.59 |
Net Debt / EBITDA Ratio | 4.42 | 4.37 | 3.01 | 2.21 | 2.56 | 3.01 |
Net Debt / FCF Ratio | -99.05 | -5.73 | -3.60 | 36.92 | 17.09 | 11.69 |
Asset Turnover | 0.57 | 0.58 | 0.56 | 0.57 | 0.54 | 0.41 |
Inventory Turnover | 322.40 | 341.93 | 329.33 | 323.16 | 302.57 | 276.96 |
Quick Ratio | 1.31 | 1.29 | 0.86 | 0.60 | 1.16 | 1.08 |
Current Ratio | 1.60 | 1.55 | 1.00 | 0.67 | 1.30 | 1.22 |
Return on Equity (ROE) | -40.48% | -40.96% | 8.70% | -0.54% | 10.21% | 9.18% |
Return on Assets (ROA) | 3.48% | 4.22% | 5.77% | 6.12% | 5.72% | 4.40% |
Return on Invested Capital (ROIC) | 7.23% | 7.86% | 8.50% | 11.72% | 7.91% | 6.70% |
Return on Capital Employed (ROCE) | 6.70% | 7.80% | 9.70% | 11.30% | 9.70% | 9.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -32.33% | -84.24% | 6.94% | -0.30% | 3.65% | 3.49% |
FCF Yield | -0.69% | -33.60% | -15.22% | 0.53% | 1.13% | 2.38% |
Buyback Yield / Dilution | 0.81% | 1.47% | -1.22% | 0.66% | -0.84% | -2.48% |